Pfizer VP: Vaccine can be adapted to fight COVID variants
Morten Sogaard, vice president of Target Sciences, Emerging Science & Innovation, for Pfizer, noted the company's mRNA vaccine has an advantage because the company can "alter the s…
Morten Sogaard, vice president of Target Sciences, Emerging Science & Innovation, for Pfizer, noted the company's mRNA vaccine has an advantage because the company can "alter the s…